Regeneron Pharmaceuticals, Inc.
HUMANIZED T CELL CO-RECEPTOR MICE

Last updated:

Abstract:

The invention provides genetically modified non-human animals that express chimeric human/non-human T cell co-receptor polypeptides (e.g., CD4, CD8.alpha., CD8.beta.), as well as embryos, cells, and tissues comprising the same. Also provided are constructs for making said genetically modified animals and methods of making the same.

Status:
Application
Type:

Utility

Filling date:

24 Sep 2020

Issue date:

11 Mar 2021